Nyrada Inc
NYR•Health Care•Biotechnology•Last updated: Dec 25
About
Nyrada Inc is a preclinical stage drug development company specializing in small molecule drugs. The company focuses on developing treatments for cardiovascular, neurological, and chronic inflammatory diseases. Its main segments include the development of a cholesterol-lowering drug and a neuroprotectant drug for traumatic brain injury and stroke.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- NYR
Related Shares
Investor Resources
Should you buy Nyrada Inc right now?
While NYR looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now